TGFB1 and neoplasm: In PBMC-transferred M-NSG murine models established with subcutaneous injection of SU-DHL-4 cells, the tumor size formed in mice with KMT2DR5432Q were significantly increased, as compared to KMT2Dwt, which could be counteracted by TGF-β inhibitor (Figure 6A).